TDF contributes clinical expertise to PeerLINC training at San Lazaro Hospital

The Tropical Disease Foundation (TDF) contributed its clinical expertise to a four-day PeerLINC training on drug-resistant tuberculosis (DR-TB) for medical staff at San Lazaro Hospital in Manila from October 26 to 29, 2026. The training combined a review of treatment recommendations with clinical exercises on selecting regimens and monitoring patients during treatment.

As PeerLINC Knowledge Hub’s host institution, TDF supports its work in strengthening the capacity of healthcare professionals to deliver DR-TB care. This support includes drawing on the expertise of TDF specialists as resource speakers, bringing their clinical experience into training sessions that help participants apply treatment guidance to the patients they encounter in practice.

Dr. Rholine Gem Veto of TDF led sessions on peripheral neuropathy, optic neuritis, QT prolongation, and chronic kidney disease. These formed part of the program’s focus on recognizing and managing adverse events associated with BPaLM/BPaL and other shorter regimens. Demonstrations and case discussions gave participants opportunities to examine symptoms and clinical findings, consider possible causes, and discuss how these could inform patient management.

In a video demonstration of the Brief Peripheral Neuropathy Screening (BPNS) tool, Dr. Veto used a scenario involving a patient who already experienced intermittent leg pain following a previous injury. The exercise illustrated the importance of documenting symptoms before treatment and comparing subsequent findings against that baseline. Participants considered how a patient’s existing condition could affect their assessment of symptoms that emerged or changed during treatment.

His sessions on optic neuritis and QT prolongation similarly connected the recognition of adverse events with treatment decisions. Case discussions encouraged participants to work through available information, assess the significance of findings, and consider the appropriate response. The format complemented the program’s broader discussion of active TB drug safety monitoring and management, including documentation and reporting.

Across the four days, the training also covered WHO-recommended DR-TB regimens and the role of laboratory diagnostics in guiding treatment. Sessions examined care for patients with coexisting conditions, including diabetes, and HIV. A workshop on regimen selection asked participants to weigh drug resistance results alongside other factors affecting a patient’s treatment options.

Through its role as host institution and the participation of its specialists, TDF helps connect PeerLINC’s training activities with clinical experience. Its contribution at San Lazaro Hospital supported a program that gave healthcare staff time to examine complex cases together and consider how treatment recommendations could guide decisions throughout a patient’s care.

Other News Articles

An official corporate certificate document layout featuring crisp typography, structured margins, and formal signatures, formally recognizing the institutional contributions of the Tropical Disease Foundation, Inc.

For any concerns about Data Privacy.

Data Privacy Officer:
John Phillip C. Ubalde
Email: [email protected]